2 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
Metys Pharmaceuticals AG
Metys Pharmaceuticals is developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy. In the US alone, in a single year, more than 400'000 patients suffer from the neuropathy caused by their life-saving cancer treatment. No drug has been approved to prevent or ...
